Barry Turnbull

1.4k total citations
18 papers, 774 citations indexed

About

Barry Turnbull is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Barry Turnbull has authored 18 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 5 papers in Immunology. Recurrent topics in Barry Turnbull's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Barry Turnbull is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Barry Turnbull collaborates with scholars based in United States, Netherlands and Sweden. Barry Turnbull's co-authors include Steven P. Treon, Christopher J. Patterson, Patricia Sheehy, Zachary R. Hunter, Leukothea Ioakimidis, Andrew R. Branagan, Stanley R. Frankel, Eva Kimby, Christos Emmanouilides and Malcolm Stoker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pain.

In The Last Decade

Barry Turnbull

17 papers receiving 752 citations

Peers

Countries citing papers authored by Barry Turnbull

Since Specialization

Citations

This map shows the geographic impact of Barry Turnbull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Turnbull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Turnbull more than expected).

Fields of papers citing papers by Barry Turnbull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Turnbull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Turnbull. The network helps show where Barry Turnbull may publish in the future.

Co-authorship network of co-authors of Barry Turnbull

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Turnbull. A scholar is included among the top collaborators of Barry Turnbull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Turnbull. Barry Turnbull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial 2016 ·Annals of Oncology ·Stephen J. O’Keefe, Jean Hoffman‐Censits, Roger B. Cohen, Ronac Mamtani, Daniel F. Heitjan, Scott Eliasof, Andrew B. Nixon, Barry Turnbull, Edward G. Garmey, (unknown), (unknown), (unknown), L. Jayaraman, Adrian M. Senderowicz, (unknown), (unknown), (unknown), David J. Vaughn, Amanda M. Smith, Naomi B. Haas	47
2	Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza) 2014 ·Clinical Journal of Pain ·Nathaniel P. Katz, (unknown), Florence Paillard, Barry Turnbull, Jeremiah Trudeau, Malcolm Stoker	20
3	Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia 2014 ·Blood ·Steven P. Treon, Christina Tripsas, Kirsten Meid, Sandra Kanan, Patricia Sheehy, Stacey Chuma, Lian Xu, Yang Cao, Guang Yang, Xia Liu, Christopher J. Patterson, Diane Warren, Zachary R. Hunter, Barry Turnbull, Irene M. Ghobrial, Jorge J. Castillo	126
4	Qutenza (Capsaicin) 8% Patch Onset and Duration of Response and Effects of Multiple Treatments in Neuropathic Pain Patients 2013 ·Clinical Journal of Pain ·(unknown), Florence Paillard, Barry Turnbull, Jeremiah Trudeau, Malcolm Stoker, Nathaniel P. Katz	41
5	Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: A meta-analysis of the Qutenza Clinical Trials Database 2013 ·Pain ·(unknown), Florence Paillard, Barry Turnbull, Jeremiah Trudeau, Malcolm Stoker, Nathaniel P. Katz	68
6	Comparative Response Assessment by Serum Immunoglobulin M M-Protein and Total Serum Immunoglobulin M After Treatment of Patients With Waldenström Macroglobulinemia 2013 ·Clinical Lymphoma Myeloma & Leukemia ·Christina Tripsas, Christopher J. Patterson, Sacha Uljon, Neal I. Lindeman, Barry Turnbull, Steven P. Treon	6
7	Familial Disease Predisposition Impacts Treatment Outcome in Patients With Waldenström Macroglobulinemia 2012 ·Clinical Lymphoma Myeloma & Leukemia ·Steven P. Treon, Christina Tripsas, Christina Hanzis, Leukothea Ioakimidis, Christopher J. Patterson, Robert Manning, Patricia Sheehy, Barry Turnbull, Zachary R. Hunter	22
8	Comparative response assessment by total serum IgM and IgM M-component in Waldenstrom’s macroglobulinemia. 2012 ·Journal of Clinical Oncology ·Christina Tripsas, Leukothea Ioakimidis, Zachary R. Hunter, Christopher J. Patterson, Robert Manning, Patricia Sheehy, Barry Turnbull, Steven P. Treon	0
9	Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia 2011 ·British Journal of Haematology ·Steven P. Treon, Guang Yang, (unknown), Leukothea Ioakimidis, Sigitas Verselis, Edward A. Fox, Lian Xu, Zachary R. Hunter, Hsiuyi Tseng, Robert Manning, Christopher J. Patterson, Patricia Sheehy, Barry Turnbull	41
10	Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab‐containing regimen 2011 ·British Journal of Haematology ·Steven P. Treon, Christina Hanzis, Robert Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy, Barry Turnbull	60
11	Treatment with a Bortezomib-Containing Regimen Is Associated with Better Therapeutic Outcomes in Patients with Waldenstrom's Macroglobulinemia Who Have Familial Disease Predisposition 2011 ·Blood ·Steven P. Treon, Zachary R. Hunter, Christina Hanzis, Christina Tripsas, Leukothea Ioakimidis, Christopher J. Patterson, Robert Manning, Patricia Sheehy, Barry Turnbull	1
12	Comparative Outcomes Following CP-R, CVP-R, and CHOP-R in Waldenström's Macroglobulinemia 2009 ·Clinical Lymphoma & Myeloma ·Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Jacob D. Soumerai, Robert Manning, Barry Turnbull, Patricia Sheehy, Steven P. Treon	41
13	Maintenance Rituximab Is Associated with Improved Progression Free and Overall Survival in Waldenstrom's Macroglobulinemia. 2009 ·Blood ·Steven P. Treon, Christina Hanzis, (unknown), (unknown), Christopher J. Patterson, Zachary R. Hunter, Barry Turnbull, Patricia Sheehy	1
14	Progression Free Survival Is Predicated by Categorical Response, and Supports the Attainment of VGPR/CR as An Objective for Long Term Disease Control in Waldenstrom's Macroglobulinemia. 2009 ·Blood ·Steven P. Treon, (unknown), Christina Hanzis, Robert Manning, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy, Barry Turnbull	1
15	Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia 2008 ·Blood ·Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, Eva Kimby	103
16	Polymorphisms in FcγRIIIA (CD16) Receptor Expression Are Associated With Clinical Response to Rituximab in Waldenström’s Macroglobulinemia 2005 ·Journal of Clinical Oncology ·Steven P. Treon, Mark Hansen, Andrew R. Branagan, Sigitas Verselis, Christos Emmanouilides, Eva Kimby, Stanley R. Frankel, Nikolaos Touroutoglou, Barry Turnbull, Kenneth C. Anderson, David G. Maloney, Edward A. Fox	185
17	A multicentre trial of Zostrum (5 percent idoxuridine in dimethyl sulphoxide) in herpes zoster. 1981 ·PubMed ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Barry Turnbull	5
18	INSULIN SECRETION AND GLUCOSE TOLERANCE IN GRANULOMA ANNULARE 1976 ·Australasian Journal of Dermatology ·(unknown), R. D. H. Stewart, Barry Turnbull, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact